glp 1 biotech Medicare's GLP-1 Bridge and what's next for (LLY:NYSE) GLP-1 use tripled among non-diabetics,

Approval of tirzepatide (brand name Mounjaro/Zepbound), an even more efficacious medication, soon followed in 2023

For a broader food list, see my guide on GLP-1 diet plan basics

At $99 as an add-on or $298 standalone, genetic insight can support a more personalized treatment conversation

Table 3 Results of a 52-week Monotherapy Trial in Adults with Type 2 Diabetes Mellitus a Figure 3 Mean HbA 1c for Adult Patients with Type 2 Diabetes Mellitus who Completed the 52-week Trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 52 (Monotherapy) Combination Therapy Add-on to Metformin In this 26-week trial, 1,091 adult patients with type 2 diabetes mellitus were randomized to liraglutide injection 0.6 mg, liraglutide injection 1.2 mg, liraglutide injection 1.8 mg, placebo, or glimepiride 4 mg (one-half of the maximal approved dose in the United States), all as add-on to metformin

Its a smart play, even as it pressures near-term margins and requires a transition period to refine its strategy for marketing and selling brand-name drugs

Stefano GB, ButtikerP, Michaelsen MM, Esch T (2025) The Anatomical and Evolutionary Impact of Pain, Pleasure, Motivation, and Cognition: Integrating Energy Metabolism and the MindBody BERN (Behavior, Exercise, Relaxation, and Nutrition) Framework